Truist Financial
IONS icon

Truist Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Truist Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
14,068
+1,222
+10% +$92K ﹤0.01% 1703
2026
Q1 		$965K Buy
12,846
+187
+1% +$14.8K ﹤0.01% 1728
2025
Q4 		$1M Buy
12,659
+7,847
+163% +$591K ﹤0.01% 1664
2025
Q3 		$315K Buy
+4,812
New +$235K ﹤0.01% 2281
2025
Q1 		– Sell
-6,847
Closed -$239K – 2595
2024
Q4 		$239K Sell
6,847
-501
-7% -$18.7K ﹤0.01% 2285
2024
Q3 		$294K Sell
7,348
-655
-8% -$30.5K ﹤0.01% 2138
2024
Q2 		$381K Sell
8,003
-1,496
-16% -$61.4K ﹤0.01% 2140
2024
Q1 		$412K Sell
9,499
-466
-5% -$22.2K ﹤0.01% 2102
2023
Q4 		$504K Buy
+9,965
New +$477K ﹤0.01% 1963
2022
Q4 		– Sell
-6,420
Closed -$284K – 2635
2022
Q3 		$284K Sell
6,420
-15,944
-71% -$672K ﹤0.01% 2114
2022
Q2 		$828K Sell
22,364
-8,906
-28% -$336K ﹤0.01% 1643
2022
Q1 		$1.16M Buy
31,270
+333
+1% +$10.9K ﹤0.01% 1557
2021
Q4 		$941K Sell
30,937
-40
-0.1% -$1.26K ﹤0.01% 1666
2021
Q3 		$1.04M Buy
30,977
+5,876
+23% +$221K ﹤0.01% 1579
2021
Q2 		$1M Buy
25,101
+3,437
+16% +$135K ﹤0.01% 1651
2021
Q1 		$974K Buy
21,664
+10,408
+92% +$580K ﹤0.01% 1614
2020
Q4 		$636K Sell
11,256
-207
-2% -$10.3K ﹤0.01% 1738
2020
Q3 		$545K Sell
11,463
-392
-3% -$21.8K ﹤0.01% 1685
2020
Q2 		$698K Buy
11,855
+183
+2% +$10.2K ﹤0.01% 1446
2020
Q1 		$551K Sell
11,672
-1,609
-12% -$89.7K ﹤0.01% 1516
2019
Q4 		$802K Buy
+13,281
New +$791K ﹤0.01% 1559

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Truist Financial's IONS Position: Q2 2026 in Review

Truist Financial increased its Ionis Pharmaceuticals (IONS) stake by 9.5% in Q2 2026, buying an estimated $92K and bringing the position to 14,068 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Truist Financial first reported a position in IONS in Q4 2019 and has held it in 21 quarters since. The position peaked at $1.16M in Q1 2022. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Truist Financial held 14,068 shares of Ionis Pharmaceuticals worth $1.12M as of Q2 2026.
  • Truist Financial bought 1,222 Ionis Pharmaceuticals shares in Q2 2026, an estimated $92K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1703 holding.
  • Truist Financial first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 21 quarters since.
  • Truist Financial's Ionis Pharmaceuticals position peaked at $1.16M in Q1 2022.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.